Stada Arzneimittel v EUIPO – Pfizer (Ruxymla) (EU Trade Mark – Judgment): ECFI 10 Nov 2021

EU trade mark – Opposition proceedings – Application for the EU word mark RUXYMLA – Earlier EU word mark RUXIMERA – Relative ground for refusal – Likelihood of confusion – Similarity of the signs – Article 8(1)(b) of Regulation (EU) 2017/1001

T-248/20, [2021] EUECJ T-248/20, ECLI:EU:T:2021:772
Bailii
European

Intellectual Property

Updated: 06 December 2021; Ref: scu.670049